XRCC1 and cancer: Studies investigating the combined effect of GST-deletions, XRCC1 (Arg194Trp and Arg399Gln), XRCC3 (Thr241Met), TP53 (Arg72Pro), and CCND1 (A870G) will be very important for further evaluate the role of these polymorphism in different cancers.